Boeing (BA): A Week to Forget

It wasn’t supposed to go this way. Boeing (BA) was again forced to delay the 787 Dreamliner, an important model in the Boeing line which is already two years over due. The project has become somewhat of a joke because of the repeated delays on this important plane. This time there are concerns with the structural make up of the airplane where the wing attaches to the fuselage and titanium or aluminum reinforcements will be brought in to ease any stress points. Furthermore, outsourcing supplies has made assemblage more complex than hoped. Boeing’s CEO tried to assure everyone that adjustments such as these are not uncommon when designing an aircraft, and he says the choice of lighter materials is not the reason for such issues. However, this has done little to assuage investors and customers that have lost patience with the string of disappointments. The most recent disappointment came when Australia’s Quantas Airways when they canceled half of their large order for 30 aircraft, citing a difficult operating environment and the need to restrain capital expenditures.

Boeing stock has taken a hit from the string of bad news, as the stock is down 13% since the announcement. The 787 project has dragged on for a very long time and was not helped by a labor dispute during production. The company has put a lot of time and energy into making the Dreamliner, and now it will not be ready for delivery for another couple of weeks at minimum. There has been no timetable released yet, and details will become available as Boeing gets a better handle on the problems.

There is no way that the last week, nor the last year could be described as particularly successful for Boeing. However, keeping an eye towards the future, we think Boeing still has a lot of growth potential. The Dreamliners huge selling point is that by using less heavy construction materials it will be 20% more fuel efficient; fuel being one of the largest (and highly volatile) expenses that struggling airlines have dealt with over the past few years. Boeing’s backlog of business has ballooned to record levels, nearly $350 billion at one point in late 2008. Even though Quantas is saving about $3 billion by cutting down their order, that is a drop in the bucket for Boeing’s backlog. Obviously, Boeing does not want to lose any orders, but at this point that have enough work to keep them busy for a very long time.

It seems there is a feeling in the market that Boeing just can’t get itself straightened out right now. Although, we currently had Boeing’s valuation at Fairly Valued coming into the week, we think that it is now down to levels where the value is extremely hard to deny. The stock might not break out of these low levels for the next few weeks, but it is reasonable to predict that in a year or two Boeing will be higher, possible much higher. The stock is trading at just over 9x fiscal 2009 expected earnings, and the shares are well below the range that we would expect to see them trade in given the current fundamentals of $49 to $63. America’s largest exporter has a game-changer in the pipeline, and when it does indeed make it to market you can bet that the stock will not be at these low valuations.

Boeing: A Week to Forget

About Ockham Research 645 Articles

Ockham Research is an independent equity research provider based in Atlanta, Georgia. Security analysis at Ockham Research is based upon the principle known as Ockham's Razor, named for the 14th- century Franciscan friar, William of Ockham. The principle states that a useful theory should utilize as few elements as possible, because efficiency is valuable. In this spirit, our goal is to make the investing environment as simple and understandable as possible, yet no simpler than is necessary.

We utilize this straightforward approach to value over 5500 securities, with key emphasis given to the study of individual securities' price-to-sales, price-to-cash earnings and other historical valuation ranges. Our long term value investing methodology is powered by the teachings of Ben Graham and it has proven to be very adept at identifying stock prices that are out of line with fundamental factors.

Ockham Research provides its research in a variety of forms and products including our company specific reports, portfolio analytics tools, newsletters, and blog posts. We also offer a white labeling research solution that can give any financial services firm their own research presence without the time and cost associated with building such a robust coverage universe of their own.

Be the first to comment

Leave a Reply

Your email address will not be published.